Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.0%

73 terminated/withdrawn out of 457 trials

Success Rate

76.9%

-9.6% vs industry average

Late-Stage Pipeline

2 trials in Phase 3/4

Results Transparency

41%

99 of 243 completed trials have results

Key Signals

71 recruiting99 with results46 terminated27 withdrawn

Enrollment Performance

Analytics

N/A

149(42.7%)

Phase 1

104(29.8%)

Phase 2

73(20.9%)

Early Phase 1

21(6.0%)

Phase 3

1(0.3%)

Phase 4

1(0.3%)

349Total

N/A(149)

Phase 1(104)

Phase 2(73)

Early Phase 1(21)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (457)

Showing 20 of 457 trials

NCT07454499Not ApplicableRecruiting

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

Role: lead

NCT06019988Not ApplicableActive Not Recruiting

Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer

Role: lead

NCT06204159Not ApplicableActive Not Recruiting

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery

Role: lead

NCT07199517Not ApplicableRecruiting

Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit

Role: lead

NCT06822049Phase 2Active Not Recruiting

Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1)

Role: collaborator

NCT04332367Phase 2Recruiting

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

Role: lead

NCT05758688Phase 2Recruiting

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Role: lead

NCT07059611Phase 2Not Yet Recruiting

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

Role: lead

NCT05916196Phase 2Recruiting

[18F]FES PET/.CT in Uterine Cancer

Role: lead

NCT06967467Enrolling By Invitation

Allergy Delabeling in Antibiotic Stewardship - Evaluations

Role: lead

NCT04339036Phase 2Recruiting

CapTemY90 for Grade 2/3 NET Liver Metastases

Role: lead

NCT06560021Not ApplicableEnrolling By Invitation

Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Role: lead

NCT06784960Not ApplicableCompleted

Communication Strategies to Increase HPV Vaccination Intention

Role: lead

NCT05968898Not ApplicableRecruiting

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Role: lead

NCT05852860Not ApplicableActive Not Recruiting

A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research

Role: lead

NCT06638554Not ApplicableRecruiting

Integrating Telehealth to Advance Lung Cancer Screening

Role: lead

NCT04532970Not ApplicableCompleted

BAPS in Botswana: The Thotloetso Trial

Role: lead

NCT07222241Not ApplicableRecruiting

Comparing Numbing Techniques in Mohs Micrographic Surgery

Role: lead

NCT07102147Not ApplicableRecruiting

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

Role: lead

NCT06458439Phase 2Recruiting

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Role: lead